Senzime Investor Relations Material
Latest events
Q2 2025
Senzime
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senzime
Access all reports
Senzime AB is a medical technology company specializing in patient monitoring systems designed to enhance safety and efficiency in healthcare. The company develops and manufactures solutions for monitoring neuromuscular function and other critical physiological parameters during and after surgery. Senzime’s products aim to reduce complications, improve outcomes, and support personalized care in operating rooms and recovery units. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm Stock Exchange.
Key slides for Senzime
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SEZI
Country
🇸🇪 Sweden